SCYNEXIS Inc. (SCYX) Financial Statements (2024 and earlier)

Company Profile

Business Address 1 EVERTRUST PLAZA
JERSEY CITY, NJ 07302-6548
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:73,500104,48493,04148,41444,15743,893
Cash and cash equivalents45,814104,48493,04141,92011,43911,469
Short-term investments27,689  6,49432,71832,424
Other undisclosed cash, cash equivalents, and short-term investments(3)     
Restricted cash and investments55   55 
Receivables 2,101861   251
Inventory, net of allowances, customer advances and progress billings 899463    
Inventory 899463    
Prepaid expense1,8063,318381271220341
Contract with customer, asset, after allowance for credit loss     
Deferred costs      314
Other current assets6243736745491
Other undisclosed current assets6382474,4113,0436,97770
Total current assets:79,061109,37798,20652,40251,46344,960
Noncurrent Assets
Operating lease, right-of-use asset2,5942,8012,9993,191
Property, plant and equipment  113298405516 
Intangible assets, net (including goodwill) 4081,056    
Intangible assets, net (excluding goodwill) 4081,056    
Restricted cash and investments163218273273273 
Deferred costs7315018770106 
Other noncurrent assets 5,5116,122573812812576
Other undisclosed noncurrent assets     314
Total noncurrent assets:8,74910,4604,3304,7511,707890
TOTAL ASSETS:87,810119,837102,53657,15353,17045,850
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,56513,5468,78010,9785,7565,538
Accounts payable5,9377,8484,6397,1773,6533,833
Accrued liabilities5,6285,6984,1413,8012,1031,705
Deferred revenue    
Debt    36 4,349
Other liabilities 5,771     
Deferred revenue and credits257
Other undisclosed current liabilities2827017,616 121 
Total current liabilities:17,61813,61626,39611,0145,87710,144
Noncurrent Liabilities
Long-term debt and lease obligation 34,39331,9493,2743,32615,08210,303
Long-term debt, excluding current maturities 34,39328,745  15,08210,303
Liabilities, other than long-term debt2,9213,345   121
Deferred revenue and credits121
Deferred revenue    
Other liabilities  3,345    
Operating lease, liability2,9213,2043,2743,326
Other undisclosed noncurrent liabilities29,64529,66946,83429,9189863,872
Total noncurrent liabilities:66,95964,96353,38233,24416,06814,296
Total liabilities:84,57778,57979,77844,25821,94524,440
Equity
Equity, attributable to parent, including:3,23341,25822,75812,89531,22521,410
Additional paid in capital425,485400,705349,351284,226248,895226,631
Accumulated deficit(422,288)(359,479)(326,613)(271,428)(217,718)(205,250)
Other undisclosed equity, attributable to parent363220974829
Total equity:3,23341,25822,75812,89531,22521,410
TOTAL LIABILITIES AND EQUITY:87,810119,837102,53657,15353,17045,850

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues5,09113,163 121257257
Revenue, net300
Cost of revenue
(Cost of Goods and Services Sold)
      
Gross profit:5,09113,163 121257257
Operating expenses(90,848)(74,001)(51,149)(49,042)(30,240)(26,577)
Other undisclosed operating income      
Operating income (loss):(85,757)(60,838)(51,149)(48,921)(29,983)(26,320)
Nonoperating income (expense)18,24824,884(7,184)(4,789)10,7791,260
Investment income, nonoperating1,3161,1702,2571,567111(124)
Interest and debt expense(5,198)(2,725)(1,766)(1,045)(1,626)(1,455)
Income (loss) from continuing operations before equity method investments, income taxes:(72,707)(38,679)(60,099)(54,755)(20,830)(26,515)
Other undisclosed income from continuing operations before income taxes5,1982,7251,7661,0451,6261,415
Income (loss) from continuing operations before income taxes:(67,509)(35,954)(58,333)(53,710)(19,204)(25,100)
Income tax expense (benefit)4,7003,0883,148 6,736 
Income (loss) from continuing operations:(62,809)(32,866)(55,185)(53,710)(12,468)(25,100)
Loss before gain (loss) on sale of properties:(32,866)(55,185)(53,710)(12,468)(25,100)
Net income (loss):(62,809)(32,866)(55,185)(53,710)(12,468)(25,100)
Other undisclosed net income attributable to parent      40
Net income (loss) available to common stockholders, diluted:(62,809)(32,866)(55,185)(53,710)(12,468)(25,060)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(62,809)(32,866)(55,185)(53,710)(12,468)(25,100)
Comprehensive income (loss), net of tax, attributable to parent:(62,809)(32,866)(55,185)(53,710)(12,468)(25,100)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: